1B8

3-[2-bromo-4-(1H-pyrazol-4-yl)thiophen-3-yl]-N-(6-chloro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-L-alanine

Created:	2012-11-21
Last modified:	2013-03-06

Find Related PDB Entry
1 entries where 1B8 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	1
Bond Count	53
Aromatic Bond Count	16

2D diagram of 1B8

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-[2-bromo-4-(1H-pyrazol-4-yl)thiophen-3-yl]-N-(6-chloro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-L-alanine
Systematic Name (OpenEye OEToolkits)	(2S)-3-[2-bromanyl-4-(1H-pyrazol-4-yl)thiophen-3-yl]-2-[(6-chloranyl-3,3-dimethyl-4H-isoquinolin-1-yl)amino]propanoic acid
Formula	C₂₁ H₂₀ Br Cl N₄ O₂ S
Molecular Weight	507.831
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Brc1scc(c1CC(NC3=NC(C)(C)Cc2cc(Cl)ccc23)C(=O)O)c4cnnc4
SMILES	CACTVS	3.370	CC1(C)Cc2cc(Cl)ccc2C(=N1)N[CH](Cc3c(Br)scc3c4c[nH]nc4)C(O)=O
SMILES	OpenEye OEToolkits	1.7.6	CC1(Cc2cc(ccc2C(=N1)NC(Cc3c(csc3Br)c4c[nH]nc4)C(=O)O)Cl)C
Canonical SMILES	CACTVS	3.370	CC1(C)Cc2cc(Cl)ccc2C(=N1)N[C@@H](Cc3c(Br)scc3c4c[nH]nc4)C(O)=O
Canonical SMILES	OpenEye OEToolkits	1.7.6	CC1(Cc2cc(ccc2C(=N1)N[C@@H](Cc3c(csc3Br)c4c[nH]nc4)C(=O)O)Cl)C
InChI	InChI	1.03	InChI=1S/C21H20BrClN4O2S/c1-21(2)7-11-5-13(23)3-4-14(11)19(27-21)26-17(20(28)29)6-15-16(10-30-18(15)22)12-8-24-25-9-12/h3-5,8-10,17H,6-7H2,1-2H3,(H,24,25)(H,26,27)(H,28,29)/t17-/m0/s1
InChIKey	InChI	1.03	DZVYKFXCGGLAAX-KRWDZBQOSA-N

Related Resource References

Resource Name	Reference
PubChem	135566783, 70789279

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.